Travoprost 0.004%/timolol 0.5% fixed combination

Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies have demonstrated the efficacy and safety of this medication used once daily for the treatment of open-angle glaucoma and ocular hypertension. This fixed combination has been compared to tra...

Full description

Saved in:
Bibliographic Details
Published inDrugs of today (Barcelona, Spain : 1998) Vol. 43; no. 2; p. 77
Main Authors Noecker, Robert J, Awadallah, Nida S, Kahook, Malik Y
Format Journal Article
LanguageEnglish
Published Spain 01.02.2007
Subjects
Antihypertensive Agents - administration & dosage
Clinical Trials as Topic
Cloprostenol - administration & dosage
Cloprostenol - analogs & derivatives
Drug Combinations
Glaucoma, Open-Angle - drug therapy
Humans
Ocular Hypertension - drug therapy
Timolol - administration & dosage
Travoprost
Online AccessGet more information

Cover

More Information
Summary:Fixed-combination travoprost/timolol solution consists of travoprost 0.004% and timolol 0.5%. Several studies have demonstrated the efficacy and safety of this medication used once daily for the treatment of open-angle glaucoma and ocular hypertension. This fixed combination has been compared to travoprost and timolol used concomitantly, latanoprost and timolol used concomitantly, latanoprost/timolol fixed combination and travoprost and timolol monotherapy. Fixed-combination medicines such as travoprost/timolol offer the potential of maximizing patient adherence by decreasing the burden of using multiple topical agents that lower intraocular pressure, and by potentially decreasing the overall cost to both the patient and the health-care system. We discuss the benefits of fixed-dose medications, report on previous clinical trials and summarize the existing data on the performance of travoprost/timolol.
ISSN:1699-3993
DOI:10.1358/dot.2007.43.2.1032058